Post-Election Outlook: FDA
The 2024 election will bring a new administration and Congress with distinct policy priorities concerning the U.S. Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA), including food enforcement, cannabis and psychedelic rescheduling, regulation of digital health and other novel technologies entering the market, as well as product approvals. Regulatory attorneys Rachel Gartner, John Vaughan, Michael Werner and Sara Klock hosted a webinar analyzing the election results as they relate to these issues.
View the presentation materials »
Duration: 59:46